Cart
sales@molnova.com
Aurora B inhibitor 1
CAS No. 937276-52-3
Aurora B inhibitor 1( —— )
Catalog No. M33019 CAS No. 937276-52-3
Aurora B inhibitor 1 is an Aurora B (Aurora-1) inhibitor (Ki <0.010 μM) with potential anticancer activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1710 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAurora B inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAurora B inhibitor 1 is an Aurora B (Aurora-1) inhibitor (Ki <0.010 μM) with potential anticancer activity for cancer research.
-
DescriptionAurora B inhibitor 1 is an Aurora B (Aurora-1) inhibitor extracted from patent WO2007059299A1, compound 1-3, has a Ki value of <0.010 uM.
-
In VitroAurora B inhibitor 1 also inhibits JAK3 and JAK2 with Kis of <0.25 μM and <0.10 μM, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number937276-52-3
-
Formula Weight529.97
-
Molecular FormulaC25H26ClF2N7O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC1(CN(C1)C2=NC(O[C@@H]3CN(C(=O)C4=C(F)C=CC(Cl)=C4)CC3)=NC(NC5=NNC(C)=C5)=C2)C6CC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. FRAYSSE, Damien, et al. AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS. WO2007059299A1.
molnova catalog
related products
-
TAS-119
TAS-119 (TAS-2104) is an orally available, selective and potent inhibitor of Aurora A with an IC50 of 1.0 nM.TAS-119 also inhibits Aurora B with an IC50 of 95 nM.
-
Tozasertib
Tozasertib (MK-0457, VX-680) is a highly potent, selective and reversible Aurora kinase inhibitor with Ki of 0.6, 18 and 4.6 nM for Aurora A, B and C, respectively.
-
XU1
XU1（Benzo[c][1,8]naphthyridin-6(5h)-One） is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
